Drug intelligence / Profile preview

anti-mouse Cd39 antibody

Development stage
Preclinical
Lead developer
Antagen Institute for Biomedical Research
Modality
Monoclonal Antibodies → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

The anti-mouse Cd39 antibody is an engineered monoclonal antibody designed to target murine CD39 (ectonucleoside triphosphate diphosphohydrolase-1). Developed for research in acute myeloid leukemia (AML), this antibody is specifically engineered with isotype selection and the removal of fucose (afucosylation) to enhance its interaction with Fc receptors (FcR). Its mechanism involves promoting the redistribution of CD39 from AML cells to effector immune cells through FcR-mediated trogocytosis, thereby reducing the immunosuppressive effects of CD39 and enhancing the efficacy of chemotherapeutic agents like daunorubicin in experimental models.

Other names
anti-Cd39 mAbanti-Cd-39 mAbanti-Cd 39 mAbanti-mouse CD39 monoclonal antibody
02

Targets

ENTPD1 (Ectonucleoside triphosphate diphosphohydrolase 1)

Beyond the preview

Go deeper on anti-mouse Cd39 antibody.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on anti-mouse Cd39 antibody.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call